Exicure, Inc. is a clinical-stage biotechnology company based in Chicago, Illinois, focusing on the development of novel therapies through its proprietary spherical nucleic acid (SNA) technology. With a robust pipeline targeting neurological disorders, immuno-oncology, inflammatory diseases, and genetic disorders, Exicure aims to revolutionize treatment approaches and enhance the efficacy of RNA-based medicine. The company's innovative platform positions it as a key player in the biopharmaceutical sector, with the potential to address unmet medical needs and transform patient care across multiple therapeutic areas. Show more

Location: 400 SEAPORT COURT, REDWOOD CITY, CA, UNITED STATES, 94063, Redwood City, CA, 94063, USA | Website: https://www.exicuretx.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE


Market Cap

25.94M

52 Wk Range

$3.10 - $15.91

Previous Close

$4.07

Open

$4.24

Volume

10,664

Day Range

$4.07 - $4.31

Enterprise Value

21.87M

Cash

4.438M

Avg Qtr Burn

-3.528M

Insider Ownership

35.38%

Institutional Own.

5.72%

Qtr Updated

09/30/25


Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.